Endologix Net Worth 2006-2019 | ELGX

Interactive chart of historical net worth (market cap) for Endologix (ELGX) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Endologix net worth as of April 03, 2020 is $0.01B.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.012B $0.143B
Endologix, Inc. develops, manufactures and markets products for the treatment of coronary and vascular diseases. A leader in the emerging field of vascular brachytherapy, Endologix, has developed a unique method for the delivery of radiation to prevent restenosis following the interventional treatment of atherosclerosis.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $61.483B 19.50
McKesson (MCK) United States $22.203B 8.71
AmerisourceBergen (ABC) United States $16.747B 11.23
Cooper (COO) United States $14.915B 23.00
Cardinal Health (CAH) United States $13.600B 8.49
Align Technology (ALGN) United States $12.144B 31.09
West Pharmaceutical Services (WST) United States $11.176B 46.71
Laboratory Of America Holdings (LH) United States $11.025B 10.02
Straumann Holding AG (SAUHF) Switzerland $10.733B 0.00
DENTSPLY SIRONA (XRAY) United States $7.850B 14.47
Henry Schein (HSIC) United States $6.646B 13.20
Merit Medical Systems (MMSI) United States $1.679B 20.69
SmileDirectClub (SDC) United States $1.491B 0.00
CONMED (CNMD) United States $1.437B 19.03
STAAR Surgical (STAA) United States $1.311B 60.73
Patterson (PDCO) United States $1.291B 8.98
Atrion (ATRI) United States $1.220B 33.35
Antares Pharma (ATRS) United States $0.334B 0.00
Invacare (IVC) United States $0.200B 0.00
Lifevantage (LFVN) United States $0.153B 12.90
Pro-Dex (PDEX) United States $0.059B 15.95
Biolase (BIOL) United States $0.007B 0.00